Pharmacology and Therapeutics in the New Millennium
Springer Science & Business Media, Sep 30, 2001 - Science - 746 pages
During the past several years tremendous advancements have been made in the field of pharmacology and therapeutics. While new therapeutic strategies are coming up, old ones are being improved by modifications, or being replaced with newer ones. The major topics covered in this book include: endothelins, current topics in cardiovascular research, molecular pharmacology, recent developments in cancer research, antioxidants, oxidants and human disease, herbal drugs, developments in neuropharmacology, myelin biology and demyelinating disease, pharmacovigilance, role of cytokines in health and disease, ocular pharmacology, detoxification of xenobiotics-biotransformation and transport, and several other topics of current interest.
The aim of this book is to fulfill the needs of the basic and clinical researchers as well as the students, particularly related to areas of current interest in pharmacology and therapeutics.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
ACE inhibitors acid activity adenosine agents agonist airway angiogenesis animals antibody antioxidants apoptosis artery atrial binding Biochem Biol bosentan brain calcium calmodulin calpain CaM BP CaMPDE isozyme cancer cardiac carotenoids cataract cellular Chem Clin clinical coronary culture decrease diabetic disease DNP-SG dose drugs Edited by S.K. effect endothelial cells enzyme expression formation function GABAB receptor gene growth factor GSTs heart hippocampal human hypertension increased induced infarction inhibition inhibitors intracellular ischemia ischemic isozyme kava levels lipid liver mechanism mediated medicine membrane metabolism mice modulation molecular morphine mRNA myocardial myocardial infarction neurons nitric oxide nitric oxide synthase opioid oxidative stress pathway patients Pharmacol Pharmacology phosphorylation Physiol plasma potential prefrontal cortex prostate protein kinase receptor antagonist regulation release reported response role schizophrenia smooth muscle stimulation studies subjects with schizophrenia substrate therapeutic therapy tissue toxicity treatment tumor vascular ventricular vitamin vitro vivo